Literature DB >> 35294867

Both male and female APPswe/PSEN1dE9 mice are impaired in spatial memory and cognitive flexibility at 9 months of age.

Lianne A Hulshof1, Leon A Frajmund1, Danny van Nuijs1, Denise C N van der Heijden1, Jinte Middeldorp2, Elly M Hol3.   

Abstract

Alzheimer's disease (AD) is the most common cause of dementia. Despite many years of research, very limited treatment options are available. Here we aim to establish a well-defined learning and memory performance test for an AD mouse model, which can be used in future studies to evaluate the effect of novel drugs, treatments, and interventions. We exposed 9-month-old APPswe/PSEN1dE9 mice to a battery of memory tests to determine which test is best suited to study memory deficits in this specific AD mouse model. Since in more recent years it has become clear that there are sex-dependent differences in AD pathology, we also assessed differences in performance between male and female mice. From our test battery, we conclude that the Barnes maze task, which spans multiple days, is better suited to study subtle learning and memory deficits in 9-month-old APPswe/PS1dE9 mice, than the 2 trial T-maze and Fear conditioning task. This test revealed deficits in both spatial memory and cognitive flexibility in the APPswe/PS1dE9 mice compared to wildtype littermates. Furthermore, we conclude that there are no sex dependent memory deficit differences in this AD mouse model at this age.
Copyright © 2022. Published by Elsevier Inc.

Entities:  

Keywords:  APPswe/PS1dE9; Alzheimer's disease; Barnes maze; Memory; Sex differences

Mesh:

Substances:

Year:  2022        PMID: 35294867     DOI: 10.1016/j.neurobiolaging.2021.12.009

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  1 in total

1.  Partial Endothelial Nitric Oxide Synthase Deficiency Exacerbates Cognitive Deficit and Amyloid Pathology in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.

Authors:  Sara Ahmed; Yu Jing; Bruce G Mockett; Hu Zhang; Wickliffe C Abraham; Ping Liu
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.